共 50 条
- [11] Long-term outcomes in patients with polyarticular juvenile idiopathic arthritis receiving adalimumab with or without methotrexate [J]. RMD OPEN, 2020, 6 (02):
- [14] Responses are maintained for up to 3 years of adalimumab treatment in polyarticular juvenile idiopathic arthritis [J]. ARTHRITIS AND RHEUMATISM, 2008, 58 (09): : S609 - S610
- [18] Adalimumab plus Methotrexate for Uveitis in Juvenile Idiopathic Arthritis [J]. NEW ENGLAND JOURNAL OF MEDICINE, 2017, 376 (17): : 1637 - 1646